CoChat

Examining Associations Between Smartphone Use and Clinical Severity in Frontotemporal Dementia: Proof-of-Concept Study

Open access

Published version of a preprint

The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.

Abstract

Background: Frontotemporal lobar degeneration (FTLD) is a leading cause of dementia in individuals aged <65 years. Several challenges to conducting in-person evaluations in FTLD illustrate an urgent need to develop remote, accessible, and low-burden assessment techniques. Studies of unobtrusive monitoring of at-home computer use in older adults with mild cognitive impairment show that declining function is reflected in reduced computer use; however, associations with smartphone use are unknown. Objective: This study aims to characterize daily trajectories in smartphone battery use, a proxy for smartphone use, and examine relationships with clinical indicators of severity in FTLD. Methods: Participants were 231 adults (mean age 52.5, SD 14.9 years; n=94, 40.7% men; n=223, 96.5% non-Hispanic White) enrolled in the Advancing Research and Treatment of Frontotemporal Lobar Degeneration (ARTFL study) and Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects (LEFFTDS study) Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) Mobile App study, including 49 (21.2%) with mild neurobehavioral changes and no functional impairment (ie, prodromal FTLD), 43 (18.6%) with neurobehavioral changes and functional impairment (ie, symptomatic FTLD), and 139 (60.2%) clinically normal adults, of whom 55 (39.6%) harbored heterozygous pathogenic or likely pathogenic variants in an autosomal dominant FTLD gene. Participants completed the Clinical Dementia Rating plus National Alzheimer’s Coordinating Center Frontotemporal Lobar Degeneration Behavior and Language Domains (CDR+NACC FTLD) scale, a neuropsychological battery; the Neuropsychiatric Inventory; and brain magnetic resonance imaging. The ALLFTD Mobile App was installed on participants’ smartphones for remote, passive, and continuous monitoring of smartphone use. Battery percentage was collected every 15 minutes over an average of 28 (SD 4.2; range 14-30) days. To determine whether temporal patterns of battery percentage varied as a function of disease severity, linear mixed effects models examined linear, quadratic, and cubic effects of the time of day and their interactions with each measure of disease severity on battery percentage. Models covaried for age, sex, smartphone type, and estimated smartphone age. Results: The CDR+NACC FTLD global score interacted with time on battery percentage such that participants with prodromal or symptomatic FTLD demonstrated less change in battery percentage throughout the day (a proxy for less smartphone use) than clinically normal participants (P<.001 in both cases). Additional models showed that worse performance in all cognitive domains assessed (ie, executive functioning, memory, language, and visuospatial skills), more neuropsychiatric symptoms, and smaller brain volumes also associated with less battery use throughout the day (P<.001 in all cases). Conclusions: These findings support a proof of concept that passively collected data about smartphone use behaviors associate with clinical impairment in FTLD. This work underscores the need for future studies to develop and validate passive digital markers sensitive to longitudinal clinical decline across neurodegenerative diseases, with potential to enhance real-world monitoring of neurobehavioral change.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2196/52831

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Visualization of raw battery percentage data for all participants binned by time of day (0=midnight; 23=11 PM).
Figure 1 Visualization of raw battery percentage data for all participants binned by time of day (0=midnight; 23=11 PM).CC BY · PubMed Central
Figure 2 Participants with prodromal frontotemporal lobar degeneration (FTLD) and those with symptomatic FTLD had flatter battery curves throughout the day (ie, a proxy for less smartphone use) than clinically normal participants on average. Error bands represent pointwise 95% CIs.
Figure 2 Participants with prodromal frontotemporal lobar degeneration (FTLD) and those with symptomatic FTLD had flatter battery curves throughout the day (ie, a proxy for less smartphone use) than clinically normal participants on average. Error bands represent pointwise 95% CIs.CC BY · PubMed Central
Figure 3 Daily battery percentage trajectories were significantly moderated by (A) executive functioning, (B) memory, (C) language, (D) visuospatial skills, (E) neuropsychiatric symptoms, and (F) total gray matter volumes. Participants with worse neurobehavioral outcomes had smaller daily decreases from peak to minimum battery percentage on average, suggesting less smartphone use throughout the day. GMV: gray matter volume; MINT: Multilingual Naming Test; NPI: Neuropsychiatric Inventory; TIV: total intracranial volume; UDS3-EF: Uniform Data Set (Version 3) Executive Function.
Figure 3 Daily battery percentage trajectories were significantly moderated by (A) executive functioning, (B) memory, (C) language, (D) visuospatial skills, (E) neuropsychiatric symptoms, and (F) total gray matter volumes. Participants with worse neurobehavioral outcomes had smaller daily decreases from peak to minimum battery percentage on average, suggesting less smartphone use throughout the day. GMV: gray matter volume; MINT: Multilingual Naming Test; NPI: Neuropsychiatric Inventory; TIV: total intracranial volume; UDS3-EF: Uniform Data Set (Version 3) Executive Function.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 75 references

Research works printed but not linked: 2

  1. Workshop on applying digital technology for early diagnosis and monitoring of Alzheimer’s disease and related dementiasNational Institutes of Health National Institute on Aging2024-04-03https://www.nia.nih.gov/research/dn/workshops/workshop-applying-digital-technology-early-diagnosis-and-monitoring
  2. Li, H, 2024, arXiv. Preprint posted online January 12, 2018

Cited by

Metadata

Authors
Paolillo, E. W., Casaletto, K. B., Clark, A. L., Taylor, J. C., Heuer, H. W., Wise, A. B., Dhanam, S., Sanderson-Cimino, M., Saloner, R., Kramer, J. H., Kornak, J., Kremers, W., Forsberg, L., Appleby, B., Bayram, E., Bozoki, A., Brushaber, D., Darby, R. R., Day, G. S., Dickerson, B. C., Domoto-Reilly, K., Elahi, F., Fields, J. A., Ghoshal, N., Graff-Radford, N., G H Hall, M., Honig, L. S., Huey, E. D., Lapid, M. I., Litvan, I., Mackenzie, I. R., Masdeu, J. C., Mendez, M. F., Mester, C., Miyagawa, T., Naasan, G., Pascual, B., Pressman, P., Ramos, E. M., Rankin, K. P., Rexach, J., Rojas, J. C., VandeVrede, L., Wong, B., Wszolek, Z. K., Boeve, B. F., Rosen, H. J., Boxer, A. L., Staffaroni, A. M., & ALLFTD Consortium
Affiliations
  • University of California, San Francisco (US)
  • Mayo Clinic (US)
  • Case Western Reserve University (US)
  • University of California San Diego (US)
  • University of North Carolina at Chapel Hill (US)
  • Vanderbilt University (US)
  • Mayo Clinic in Florida (US)
  • Harvard University (US)
  • James J. Peters VA Medical Center (US)
  • Washington University in St. Louis (US)
  • Columbia University (US)
  • Brown University (US)
  • University of British Columbia (CA)
  • Weill Cornell Medicine (US)
  • University of California, Los Angeles (US)
  • Icahn School of Medicine at Mount Sinai (US)
  • University of Colorado Anschutz (US)
Corresponding author
Paolillo, Emily W
Venue
JMIR Aging
Published
2024-06-26
Volume
7
Pages
e52831
ISSN
2561-7605 (ISSN-L)
OpenAlex
W4400039427
Cited by
16
References
75
Citations by year
2026: 9 · 2025: 6 · 2024: 1
FWCI
4.70
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • JMIR Aging (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion, cc-by)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
  • Digital Commons@Becker (Washington University School of Medicine) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • UNC Libraries
Funders
  • U.S. Department of Veterans Affairs (IK2CX002180)
  • Alzheimer's Association (AARF-23-1145318, AARF-22, AARF-22-974065)
  • Association for Frontotemporal Degeneration
  • Eli Lilly and Company
  • Pfizer
  • Biogen
  • University of Southern California
  • University of Pennsylvania
  • Emory University
  • Northwestern University
  • Cleveland Clinic
  • University of Washington
  • Johns Hopkins University
  • CurePSP
  • Demensförbundet
  • Horizon Pharmaceuticals
  • Rainwater Charitable Foundation
  • University of Toronto
  • Eisai
  • Universiteit Antwerpen
  • National Institutes of Health (1r21ns114764-01a1, AG016976, AG019724, AG021886, AG063911, AG045390, AG058233, NS050915, AG032306, NS092089)
  • Centers for Disease Control and Prevention
  • University of California, San Diego
  • University of California, San Francisco (AG019724)
  • National Institute on Aging (R01AG058233, K23AG059888, U01AG057195, U01AG016976, K23AG061253, U01AG045390, R01AG032306, K23AG064029, RF1AG077557, RF1AG032289, U19AG032438, K24AG045333, R01AG038791, U19AG063911, R01AG077557, P01AG019724, P30AG062422, K23AG073514, P30AG066514, P30AG062677, P30AG066509, R01AG032289, U24AG021886)
  • National Institute of Neurological Disorders and Stroke (R21 NS114764, K08NS105916, RF1NS050915, R56NS050915, U54NS092089, U01NS120901, R25NS098999, R01NS050915, U01NS100610)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Social Sciences › Psychology › Clinical Psychology › Historical and Modern Theater Studies
  • Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Keywords
frontotemporal lobar degeneration, frontotemporal dementia, smartphone use, remote monitoring, disease severity, familial frontotemporal lobar degeneration, neurobehavioral symptoms, neuropsychiatric symptoms, neuropsychological assessment, mobile health, non-intrusive monitoring
MeSH terms
Smartphone, Proof of Concept Study, Adult, Aged, Female, Humans, Longitudinal Studies, Male, Middle Aged, Neuropsychological Tests, Severity of Illness Index, Frontotemporal Dementia, Mobile Applications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.